Indo-Irish Biotech startup CyGenica secures funding from SOSV to accelerate cancer and rare genetic disease therapy

CyGenica’s disruptive technology addresses the problem of delivering large-molecule therapeutics into living cells without damaging them or triggering an adverse immune response.CyGenica’s disruptive technology addresses the problem of delivering large-molecule therapeutics into living cells without damaging them or triggering an adverse immune response.Read More